Table 1 Characteristics of the study population

From: Statin use and risk for ovarian cancer: a Danish nationwide case–control study

Characteristic

Cases ( n =4103)

Controls ( n =58 706)

Drug use

Statins

434 (10.6)

6445 (11.0)

Oral contraceptives

224 (5.5)

5070 (8.6)

Hormonal replacement therapy

1484 (36.2)

18 850 (32.1)

Paracetamol

587 (14.3)

9513 (16.2)

Low-dose aspirin

494 (12.0)

7536 (12.8)

Age at diagnosis/index date (years)

30–39

104 (2.5)

1454 (2.5)

40–49

480 (11.7)

6879 (11.7)

50–59

1041 (25.4)

14 991 (25.5)

60–69

1233 (30.1)

17 632 (30.0)

70–84

1245 (30.3)

17 750 (30.2)

Education

Basic

82 (2.0)

1522 (2.6)

Higher

853 (20.8)

11 576 (19.7)

Vocational

3026 (73.8)

43 606 (74.3)

Unknown

142 (3.5)

2002 (3.4)

Personal income

Low

1427 (34.8)

19 854 (33.8)

Medium

1372 (33.4)

19 507 (33.2)

High

1304 (31.8)

19 345 (33.0)

Parity

0

901 (22.0)

9528 (16.2)

1

797 (19.4)

10 641 (18.1)

2

1521 (37.1)

23 218 (39.5)

3

884 (21.5)

15 319 (26.1)

Medical history

Infertility

163 (4.0)

1443 (2.5)

Endometriosis

71 (1.7)

857 (1.5)

Diabetes mellitus

189 (4.6)

2792 (4.8)

Chronic obstructive pulmonary disease or asthma

167 (4.1)

2882 (4.9)

Ischaemic cardio- or cerebrovascular disease

321 (7.8)

5666 (9.7)

Previous surgical procedure

Hysterectomy

369 (9.0)

4772 (8.1)

Tubal sterilisation

200 (4.9)

3453 (5.9)